Le Lézard
Classified in: Health, Business
Subjects: ERN, ERP, DIV

Aflac Incorporated Announces First Quarter Results, Reports First Quarter Net Earnings of $1.9 Billion, Declares Second Quarter Cash Dividend


COLUMBUS, Ga., May 1, 2024 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its first quarter results.

Total revenues were $5.4 billion in the first quarter of 2024, compared with $4.8 billion in the first quarter of 2023, reflecting net investment gains. Net earnings were $1.9 billion, or $3.25 per diluted share, compared with $1.2 billion, or $1.94 per diluted share a year ago.

Net earnings in the first quarter of 2024 included net investment gains of $951 million, or $1.65 per diluted share, compared with net investment gains of $123 million, or $0.20 per diluted share a year ago. These net investment gains were driven by net gains of $703 million on certain derivatives and foreign currency; net gains from sales and redemptions of $173 million; and a $76 million gain from an increase in the fair value of equity securities, offset by a $1 million increase in the company's current expected credit losses (CECL) reserves.

Adjusted earnings* in the first quarter were $961 million, compared with $953 million in the first quarter of 2023, reflecting an increase of 0.8%. Adjusted earnings per diluted share* increased 7.1% to $1.66 in the quarter. Variable investment income ran $11 million, or $0.01 per share, below the company's long-term return expectations. The weaker yen/dollar exchange rate negatively impacted adjusted earnings per share by $0.08.

The average yen/dollar exchange rate in the first quarter of 2024 was 148.67, or 11.0% weaker than the average rate of 132.30 in the first quarter of 2023.

Shareholders' equity was $23.5 billion, or $41.27 per share, at March 31, 2024, compared with $19.8 billion, or $32.65 per share, at March 31, 2023. Shareholders' equity at the end of the first quarter included a cumulative decrease of $1.5 billion for the effect of the change in discount rate assumptions on insurance reserves, compared with a corresponding cumulative decrease of $4.9 billion at March 31, 2023 and a net unrealized gain on investment securities and derivatives of $1.1 billion, compared with a net unrealized gain of $1.3 billion at March 31, 2023. Shareholders' equity at the end of the first quarter also included an unrealized foreign currency translation loss of $4.7 billion, compared with an unrealized foreign currency translation loss of $3.6 billion at March 31, 2023. The annualized return on average shareholders' equity in the first quarter was 33.0%.

Shareholders' equity excluding AOCI (or adjusted book value*) was $28.6 billion, or $50.22 per share at March 31, 2024, compared with $27.1 billion, or $44.66 per share, at March 31, 2023. The annualized adjusted return on equity excluding foreign currency impact* in the first quarter was 14.3%.

AFLAC JAPAN

In yen terms, Aflac Japan's net earned premiums were ¥269.9 billion for the quarter, or 6.0% lower than a year ago, mainly due to the prior year reinsurance transactions and limited-pay policies reaching paid-up status. Adjusted net investment income increased 19.3% to ¥96.6 billion, mainly due to lower hedge costs, the favorable impact of the weakening yen on U.S. dollar investments, and higher variable investment income. Total adjusted revenues in yen declined 0.4% to ¥367.6 billion. Pretax adjusted earnings in yen for the quarter increased 15.6% on a reported basis to ¥120.6 billion, primarily due to lower benefits and expenses during the quarter. Pretax adjusted earnings increased 9.3% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment increased to 32.8%, compared with 28.2% a year ago.

In dollar terms, net earned premiums decreased 16.3% to $1.8 billion in the first quarter. Adjusted net investment income increased 6.1% to $648 million. Total adjusted revenues declined by 11.4% to $2.5 billion. Pretax adjusted earnings increased 2.8% to $810 million.

For the quarter, total new annualized premium sales (sales) decreased 5.1% to ¥12.5 billion, or $84 million, primarily reflecting softer first sector sales.

AFLAC U.S.

Aflac U.S. net earned premiums increased 3.3% to $1.5 billion in the first quarter compared to the prior year due primarily to sales recovery in the prior year and continued improvement in persistency. Adjusted net investment income increased 4.6% to $206 million, largely due to higher variable investment income and a shift to higher-yielding fixed-income investments. Total adjusted revenues were up 2.3% to $1.7 billion. Pretax adjusted earnings were $356 million, 1.1% higher than a year ago, primarily due to higher revenue and lower expenses offset by higher benefits. The pretax adjusted profit margin for the U.S. segment was 21.0%, compared with 21.2% a year ago.

Aflac U.S. sales decreased 5.2% in the quarter to $298 million, reflecting continued strong underwriting discipline.

CORPORATE AND OTHER

For the quarter, total adjusted revenues increased 91.5% to $247 million compared to the prior year primarily due to reinsurance transactions in the fourth quarter of 2023 resulting in an increase to both total net earned premiums and adjusted net investment income, which also increased due to a lower volume of tax credit investments. Total benefits and adjusted expenses increased $114 million compared to prior year primarily as a result of the increased reinsurance activity. Pretax adjusted earnings were a loss of $3 million, compared with a loss of $7 million a year ago.

DIVIDEND AND CAPITAL RETURNED TO SHAREHOLDERS

The board of directors declared the second quarter dividend of $0.50 per share, payable on June 3, 2024 to shareholders of record at the close of business on May 22, 2024.

In the first quarter, Aflac Incorporated deployed $750 million in capital to repurchase 9.3 million of its common shares. At the end of March 2024, the company had 68.5 million remaining shares authorized for repurchase.

OUTLOOK

Commenting on the company's results, Aflac Incorporated Chairman, Chief Executive Officer and President Daniel P. Amos stated: "Aflac delivered very solid earnings for the quarter. We have continued to actively concentrate on driving profitable growth in the U.S. and Japan with new products and distribution strategies. We believe our strategy will continue to create long-term value for shareholders. 

"Looking at our operations in Japan, we have maintained disciplined underwriting and expense management to drive strong pretax profit margins. We expect sales campaigns around our 50th anniversary in Japan starting in the second quarter to get us back on track for the year. 

"In the U.S., we continue to focus on more profitable growth by exercising a stronger underwriting discipline with an emphasis on persistency. As a result, we are seeing positive results in both net earned premiums growth and persistency. At the same time, we continue our disciplined approach to expense management and maintaining a strong pretax margin. We expect to drive further improvements throughout the year.

"We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management. We treasure our track record of 41 consecutive years of dividend growth and remain committed to extending it, supported by our financial strength. In the quarter, we repurchased a record $750 million in shares and intend to continue our balanced approach of investing in growth and driving long-term operating efficiencies."

*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.

ABOUT AFLAC INCORPORATED

Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than 68 years to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 18 consecutive years (2024), Fortune's World's Most Admired Companies for 23 years (2024) and Bloomberg's Gender-Equality Index for the fourth consecutive year (2023). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2023) for 10 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/espanol. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."

1 LIMRA 2022 U.S. Supplemental Health Insurance Total Market Report

A copy of Aflac's financial supplement for the quarter can be found on the "Investors" page at aflac.com.

Aflac Incorporated will webcast its quarterly conference call via the "Investors" page of aflac.com at 7:00 a.m. (ET) on May 2, 2024.

Note: Tables within this document may not foot due to rounding.

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT

(UNAUDITED ? IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)








THREE MONTHS ENDED MARCH 31,


2024


2023


% Change

Total revenues


$   5,436


$   4,800


13.3 %

Benefits and claims, net


2,010


2,150


(6.5)

Total acquisition and operating expenses


1,256


1,308


(4.0)

Earnings before income taxes


2,170


1,342


61.7

Income taxes


291


154



Net earnings


$   1,879


$   1,188


58.2 %

Net earnings per share ? basic


$     3.27


$     1.94


68.6 %

Net earnings per share ? diluted


3.25


1.94


67.5

Shares used to compute earnings per share (000):







Basic


574,886


611,205


(5.9) %

Diluted


577,482


613,950


(5.9)

Dividends paid per share


$     0.50


$     0.42


19.0 %

 

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET

(UNAUDITED ? IN MILLIONS, EXCEPT FOR SHARE AMOUNTS)








MARCH 31,


2024


2023


% Change

Assets:







Total investments and cash


$ 111,716


$ 120,500


(7.3) %

Deferred policy acquisition costs


8,819


9,267


(4.8)

Other assets


4,207


5,199


(19.1)

Total assets


$ 124,742


$ 134,966


(7.6) %

Liabilities and shareholders' equity:







Policy liabilities


$  85,364


$   99,933


(14.6) %

Notes payable and lease obligations


7,912


7,420


6.6

Other liabilities


7,929


7,829


1.3

Shareholders' equity


23,537


19,784


19.0

Total liabilities and shareholders' equity


$ 124,742


$ 134,966


(7.6) %

Shares outstanding at end of period (000)


570,278


605,952


(5.9) %

 

NON-U.S. GAAP FINANCIAL MEASURES

This document includes references to the Company's financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company's business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

 The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:

 

RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS

(UNAUDITED ? IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)








THREE MONTHS ENDED MARCH 31,


2024


2023


% Change








Net earnings


$ 1,879


$   1,188


58.2 %








Items impacting net earnings:







Adjusted net investment (gains) losses


(1,009)


(209)



Other and non-recurring (income) loss


2


?



Income tax (benefit) expense on items excluded

from adjusted earnings


89


(26)










Adjusted earnings


961


953


0.8 %

Current period foreign currency impact 1


44


N/A



Adjusted earnings excluding current period foreign
     currency impact 2


$ 1,005


$      953


5.5 %








Net earnings per diluted share


$   3.25


$     1.94


67.5 %








Items impacting net earnings:







Adjusted net investment (gains) losses


(1.75)


(0.34)



Other and non-recurring (income) loss


?


?



Income tax (benefit) expense on items excluded

from adjusted earnings


0.15


(0.04)










Adjusted earnings per diluted share


1.66


1.55


7.1 %

Current period foreign currency impact 1


0.08


N/A



Adjusted earnings per diluted share excluding
     current period foreign currency impact 2


$   1.74


$     1.55


12.3 %



1

Prior period foreign currency impact reflected as "N/A" to isolate change for current period only.

2

Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes.

 

RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES

(UNAUDITED ? IN MILLIONS)








THREE MONTHS ENDED MARCH 31,


2024


2023


% Change








Net investment (gains) losses


$   (951)


$   (123)


673.2 %








Items impacting net investment (gains) losses:







Amortized hedge costs


(6)


(58)



Amortized hedge income


28


29



Net interest income (expense) from derivatives associated

     with certain investment strategies


(88)


(69)



Impact of interest from derivatives associated with

     notes payable1


8


12










Adjusted net investment (gains) losses


$  (1,009)


$   (209)


382.8 %



1

Amounts are included with interest expenses that are a component of adjusted expenses.

 

RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME

(UNAUDITED ? IN MILLIONS)








THREE MONTHS ENDED MARCH 31,


2024


2023


% Change








Net investment income


$  1,000


$    943


6.0 %








Items impacting net investment income:







Amortized hedge costs


(6)


(58)



Amortized hedge income


28


29



Net interest income (expense) from derivatives associated

     with certain investment strategies


(88)


(69)










Adjusted net investment income


$    934


$    845


10.5 %

 

RECONCILIATION OF U.S. GAAP BOOK VALUE TO ADJUSTED BOOK VALUE 

(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)








MARCH 31,


2024


2023


% Change

U.S. GAAP book value


$       23,537


$       19,784



Less:







Unrealized foreign currency translation gains (losses)


(4,666)


(3,618)



Unrealized gains (losses) on securities and derivatives


1,066


1,263



Effect of changes in discount rate assumptions


(1,495)


(4,894)



Pension liability adjustment


(7)


(29)



Total AOCI


(5,102)


(7,278)



Adjusted book value


$       28,639


$       27,062



Add:







Unrealized foreign currency translation gains (losses)


(4,666)


(3,618)



Adjusted book value including unrealized foreign currency translation gains (losses)


$       23,973


$       23,444










Number of outstanding shares at end of period (000)


570,278


605,952










U.S. GAAP book value per common share


$         41.27


$         32.65


26.4 %

Less:







Unrealized foreign currency translation gains (losses) per common share


(8.18)


(5.97)



Unrealized gains (losses) on securities and derivatives per common share


1.87


2.08



Effect of changes in discount rate assumptions

     per common share


(2.62)


(8.08)



Pension liability adjustment per common share


(0.01)


(0.05)



Total AOCI per common share


(8.95)


(12.01)



Adjusted book value per common share


$         50.22


$         44.66


12.4 %

Add:







Unrealized foreign currency translation gains (losses) per common share


(8.18)


(5.97)



Adjusted book value including unrealized foreign currency translation gains (losses) per common share


$         42.04


$         38.69


8.7 %

 

RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE 

(EXCLUDING IMPACT OF FOREIGN CURRENCY)






THREE MONTHS ENDED MARCH 31,


2024


2023

U.S. GAAP ROE - Net earnings1


33.0 %


23.8 %

Impact of excluding unrealized foreign currency translation gains (losses)


(5.1)


(3.2)

Impact of excluding unrealized gains (losses) on securities and derivatives


1.3


0.2

Impact of excluding effect of changes in discount rate assumptions


(2.4)


(3.1)

Impact of excluding pension liability adjustment


?


?

Impact of excluding AOCI


(6.2)


(6.1)

U.S. GAAP ROE - less AOCI


26.8


17.7

Differences between adjusted earnings and net earnings2


(13.1)


(3.5)

Adjusted ROE - reported


13.7


14.2

Less: Impact of foreign currency3


(0.6)


N/A

Adjusted ROE, excluding impact of foreign currency


14.3


14.2



1

U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

2

See separate reconciliation of net income to adjusted earnings.

3

Impact of foreign currency is calculated by restating all foreign currency components of the income statement to the weighted average foreign currency exchange rate for the comparable prior year period. The impact is the difference of the restated adjusted earnings compared to reported adjusted earnings. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure.

 

EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS1

(SELECTED PERCENTAGE CHANGES, UNAUDITED)


THREE MONTHS ENDED MARCH 31, 2024


Including

Currency

Changes


Excluding

Currency

Changes2

Net earned premiums3


(6.3) %


0.3 %

Adjusted net investment income4


10.5


13.8

Total benefits and expenses


(5.5)


0.9

Adjusted earnings


0.8


5.5

Adjusted earnings per diluted share


7.1


12.3



1

Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

2

Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes. 

3

Net of reinsurance

4

Refer to previously defined adjusted net investment income.

 

FORWARD-LOOKING INFORMATION

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The company desires to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as "expect," "anticipate," "believe," "goal," "objective," "may," "should," "estimate," "intends," "projects," "will," "assumes," "potential," "target," "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.

The company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:

(PRNewsfoto/Aflac Incorporated)

Analyst and investor contact - David A. Young, 706.596.3264; 800.235.2667 or [email protected]

Media contact - Ines Gutzmer, 762.207.7601 or [email protected]

SOURCE Aflac Incorporated


These press releases may also interest you

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 10:12
AnX Robotica, the leader in advanced gastrointestinal visualization technologies, is happy to announce the appointment of two industry veterans to the leadership team....

at 07:13
Webblogic®, a pioneer in medical device manufacturing technology, is set to launch its comprehensive range of advanced manufacturing and packaging equipment specifically designed for the Medical Device, Pharma, and Life Sciences industries. In...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)



News published on and distributed by: